about
Interactions of AChE with Aβ Aggregates in Alzheimer's Brain: Therapeutic Relevance of IDN 5706Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's diseaseA direct method to visualise the aryl acylamidase activity on cholinesterases in polyacrylamide gelsSelective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodentReduction in CHT1-mediated choline uptake in primary neurons from presenilin-1 M146V mutant knock-in miceCholinergic modulation of event-related oscillations (ERO).Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's diseaseQuantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease.Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment.Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse modelRate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variationButyrylcholinesterase is associated with β-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer diseaseBiochemical differentiation of cholinesterases from normal and Alzheimer's disease cortex.Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's diseaseMolecular interaction study of N1-p-fluorobenzyl-cymserine with TNF-α , p38 kinase and JNK kinase.A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs.PP2A ligand ITH12246 protects against memory impairment and focal cerebral ischemia in mice.Assessment of in-vitro cholinesterase inhibitory and thrombolytic potential of bark and seed extracts of Tamarindus indica (L.) relevant to the treatment of Alzheimer's disease and clotting disorders.Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.Benzothiazepine CGP37157 and its isosteric 2'-methyl analogue provide neuroprotection and block cell calcium entryThree-way interaction model to trace the mechanisms involved in Alzheimer's disease transgenic miceTargeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's disease.
P2860
Q21129335-4E8A7789-8FE9-4580-9713-57C657364CDCQ21562116-F45A7E36-4EEC-4F4D-B5CE-13F7712DA72EQ24795240-53AC8F8D-2817-4B7C-93F1-F447900C0E89Q28578059-1677EA26-DF47-4296-828D-84CB410B4AB1Q28587827-21E48CD5-B737-44CD-8A63-D71D38525AB6Q30413740-705909CF-DA4E-499F-B517-19DF80FA1C4AQ30497749-8AA5A493-EA9D-4C25-9ACC-9A9D06DCA2F0Q33708963-15BEC536-9DC9-4C9D-801C-4A8A01A31C0EQ33968308-7701F022-29DC-4115-AD95-8C9E7107775AQ34797526-B6B41160-0F7B-40D5-B536-0A41922BA72DQ35487636-D17DABFD-5107-46D9-AC97-11FA6D35F78DQ35634147-06D38A7F-9D0E-4A78-95F6-706F7662B0CAQ35757336-786A26D6-FE50-4D51-B415-0CD6726C567DQ36601142-B929159C-ECE0-45D8-A71F-06161FA93C56Q36727886-1F284AE1-2117-4E13-BEEA-84D101DAFD91Q37070395-0C192782-0267-4C2F-BFB8-3FBD1EC06F1BQ37104891-711F3D50-333E-467B-95D4-42DD11EDDEC6Q37186184-1E5DE270-6EAB-4F31-87C7-3158B3747FCCQ37621143-E2005F5F-5A0B-4F63-AFC2-D0BCF451F17EQ38262767-DE2CFC8C-06D2-498A-8016-13D8DD60729FQ39302882-5F0DA2DF-E62E-4149-A4A0-FEA1727F9E2FQ41876717-2811D6A4-0CA8-4904-B8DE-DB1F1606FF9AQ42655707-E5DF51B6-A817-4E99-987A-643DF022FB55
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Cholinesterases and the pathology of Alzheimer disease.
@ast
Cholinesterases and the pathology of Alzheimer disease.
@en
Cholinesterases and the pathology of Alzheimer disease.
@nl
type
label
Cholinesterases and the pathology of Alzheimer disease.
@ast
Cholinesterases and the pathology of Alzheimer disease.
@en
Cholinesterases and the pathology of Alzheimer disease.
@nl
prefLabel
Cholinesterases and the pathology of Alzheimer disease.
@ast
Cholinesterases and the pathology of Alzheimer disease.
@en
Cholinesterases and the pathology of Alzheimer disease.
@nl
P1476
Cholinesterases and the pathology of Alzheimer disease
@en
P2093
P407
P478
P577
1995-01-01T00:00:00Z